Health Care & Life Sciences » Pharmaceuticals | Pernix Therapeutics Holdings Inc.

Pernix Therapeutics Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
84,872.10
121,747.00
175,850.00
140,856.00
146,068.00
Cost of Goods Sold (COGS) incl. D&A
52,546.60
78,155.00
146,103.00
129,458.00
117,847.00
Gross Income
32,325.50
43,592.00
29,747.00
11,398.00
28,221.00
SG&A Expense
66,637.50
66,069.00
102,750.00
104,913.00
77,588.00
EBIT
34,312.10
22,477.00
-
93,515.00
49,367.00
Unusual Expense
11,428.30
7,336.00
29,548.00
36,956.00
7,605.00
Non Operating Income/Expense
3,397.70
401.00
582.00
823.00
1,951.00
Interest Expense
4,182.70
19,100.00
38,277.00
37,857.00
36,957.00
Pretax Income
46,391.30
49,011.00
141,253.00
169,151.00
76,768.00
Income Tax
20,756.00
13,725.00
7,062.00
439.00
373.00
Consolidated Net Income
25,635.30
35,286.00
148,315.00
169,590.00
77,141.00
Net Income
25,635.30
35,286.00
148,315.00
169,590.00
77,141.00
Net Income After Extraordinaries
25,635.30
35,286.00
148,315.00
169,590.00
77,141.00
Net Income Available to Common
25,635.30
35,286.00
148,315.00
169,590.00
77,141.00
EPS (Basic)
7.00
9.30
278.10
21.67
7.21
Basic Shares Outstanding
3,644.40
3,787.10
533.30
7,827.00
10,706.00
EPS (Diluted)
7.03
9.32
278.11
21.67
7.21
Diluted Shares Outstanding
3,644.40
3,787.10
533.30
7,827.00
10,706.00
EBITDA
25,635.80
10,522.00
21,692.00
7,300.00
23,968.00
Non-Operating Interest Income
134.00
303.00
157.00
-
-

About Pernix Therapeutics Holdings

View Profile
Address
10 North Park Place
Morristown New Jersey 07960
United States
Employees -
Website http://www.pernixtx.com
Updated 09/14/2018
Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.